At the news
? NEUTRALIMPACT 3/10 8-K filed Nov 6, 2026 at 16:04 ET
Nkarta filed an 8-K announcing a webcast on November 9, 2026 to review initial clinical data for NKX019 in myositis and systemic sclerosis from the Ntrust program, being presented at ACR Convergence 2026. No clinical data or financial results were disclosed in the filing.
- Webcast scheduled for November 9, 2026 at 8:00 a.m. ET
- Initial clinical data from Ntrust program evaluating NKX019 in myositis and systemic sclerosis
- Data being presented at ACR Convergence 2026 in Orlando
- Ntrust-1 (NCT06557265) and Ntrust-2 (NCT06733935) are multi-center, open-label, dose-escalation trials
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access